Selected research
Industry Research
Reusable Insulin Injection Pen Industry Research Report 2026
Market perspective
The global Reusable Insulin Injection Pen market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Reusable Insulin Injection Pen is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Reusable Insulin Injection Pen is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Reusable Insulin Injection Pen is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Reusable Insulin Injection Pen include Novo Nordisk, Eli Lilly and Company, Sanofi, Owen Mumford, Ypsomed, Tonghua Dongbao Pharmaceutical Co.,Ltd., Gan & Lee Pharmaceuticals, Jiangsu Delfu Medical Device Co.,Ltd. and Wanhai Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Reusable Insulin Injection Pen market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Reusable Insulin Injection Pen Market by Company
Novo Nordisk
Eli Lilly and Company
Sanofi
Owen Mumford
Ypsomed
Tonghua Dongbao Pharmaceutical Co.,Ltd.
Gan & Lee Pharmaceuticals
Jiangsu Delfu Medical Device Co.,Ltd.
Wanhai Medical
Phray Technology Co., Ltd.
Shanghai Umitai Medical Technology Co.,Ltd
Shandong Kangli Medical Equipment Technology Co., Ltd.
Gangan Medical Technology Jiangsu Co., LTD
Lepu Medical Technology (Beijing) Co., Ltd.
Reusable Insulin Injection Pen Segment by Type
Mechanical Force
Electric Force
Optical Force
Reusable Insulin Injection Pen Segment by Application
Hospital & Clinic
Retail Pharmacies
Online Channel
Reusable Insulin Injection Pen Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Reusable Insulin Injection Pen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Reusable Insulin Injection Pen and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Reusable Insulin Injection Pen.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Reusable Insulin Injection Pen manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Reusable Insulin Injection Pen by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Reusable Insulin Injection Pen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mechanical Force
- Electric Force
- Optical Force
Applications
- Hospital & Clinic
- Retail Pharmacies
- Online Channel
Companies covered
- Novo Nordisk
- Eli Lilly and Company
- Sanofi
- Owen Mumford
- Ypsomed
- Tonghua Dongbao Pharmaceutical Co.,Ltd.
- Gan & Lee Pharmaceuticals
- Jiangsu Delfu Medical Device Co.,Ltd.
- Wanhai Medical
- Phray Technology Co., Ltd.
- Shanghai Umitai Medical Technology Co.,Ltd
- Shandong Kangli Medical Equipment Technology Co., Ltd.
- Gangan Medical Technology Jiangsu Co., LTD
- Lepu Medical Technology (Beijing) Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Reusable Insulin Injection Pen Market Size (2021-2032)
- 2.2.2 Global Reusable Insulin Injection Pen Sales (2021-2032)
- 2.2.3 Global Reusable Insulin Injection Pen Market Average Price (2021-2032)
- 2.3 Reusable Insulin Injection Pen by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Mechanical Force
- 2.3.3 Electric Force
- 2.3.4 Optical Force
- 2.4 Reusable Insulin Injection Pen by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital & Clinic
- 2.4.3 Retail Pharmacies
- 2.4.4 Online Channel
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Reusable Insulin Injection Pen Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Reusable Insulin Injection Pen Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Reusable Insulin Injection Pen Revenue of Manufacturers (2021-2026)
- 3.4 Global Reusable Insulin Injection Pen Average Price by Manufacturers (2021-2026)
- 3.5 Global Reusable Insulin Injection Pen Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Reusable Insulin Injection Pen, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Reusable Insulin Injection Pen, Product Type & Application
- 3.8 Global Manufacturers of Reusable Insulin Injection Pen, Established Date
- 3.9 Global Reusable Insulin Injection Pen Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novo Nordisk
- 4.1.1 Novo Nordisk Company Information
- 4.1.2 Novo Nordisk Business Overview
- 4.1.3 Novo Nordisk Reusable Insulin Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novo Nordisk Reusable Insulin Injection Pen Product Portfolio
- 4.1.5 Novo Nordisk Recent Developments
- 4.2 Eli Lilly and Company
- 4.2.1 Eli Lilly and Company Company Information
- 4.2.2 Eli Lilly and Company Business Overview
- 4.2.3 Eli Lilly and Company Reusable Insulin Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Eli Lilly and Company Reusable Insulin Injection Pen Product Portfolio
- 4.2.5 Eli Lilly and Company Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Reusable Insulin Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Reusable Insulin Injection Pen Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 Owen Mumford
- 4.4.1 Owen Mumford Company Information
- 4.4.2 Owen Mumford Business Overview
- 4.4.3 Owen Mumford Reusable Insulin Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Owen Mumford Reusable Insulin Injection Pen Product Portfolio
- 4.4.5 Owen Mumford Recent Developments
- 4.5 Ypsomed
- 4.5.1 Ypsomed Company Information
- 4.5.2 Ypsomed Business Overview
- 4.5.3 Ypsomed Reusable Insulin Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Ypsomed Reusable Insulin Injection Pen Product Portfolio
- 4.5.5 Ypsomed Recent Developments
- 4.6 Tonghua Dongbao Pharmaceutical Co.,Ltd.
- 4.6.1 Tonghua Dongbao Pharmaceutical Co.,Ltd. Company Information
- 4.6.2 Tonghua Dongbao Pharmaceutical Co.,Ltd. Business Overview
- 4.6.3 Tonghua Dongbao Pharmaceutical Co.,Ltd. Reusable Insulin Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Tonghua Dongbao Pharmaceutical Co.,Ltd. Reusable Insulin Injection Pen Product Portfolio
- 4.6.5 Tonghua Dongbao Pharmaceutical Co.,Ltd. Recent Developments
- 4.7 Gan & Lee Pharmaceuticals
- 4.7.1 Gan & Lee Pharmaceuticals Company Information
- 4.7.2 Gan & Lee Pharmaceuticals Business Overview
- 4.7.3 Gan & Lee Pharmaceuticals Reusable Insulin Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Gan & Lee Pharmaceuticals Reusable Insulin Injection Pen Product Portfolio
- 4.7.5 Gan & Lee Pharmaceuticals Recent Developments
- 4.8 Jiangsu Delfu Medical Device Co.,Ltd.
- 4.8.1 Jiangsu Delfu Medical Device Co.,Ltd. Company Information
- 4.8.2 Jiangsu Delfu Medical Device Co.,Ltd. Business Overview
- 4.8.3 Jiangsu Delfu Medical Device Co.,Ltd. Reusable Insulin Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jiangsu Delfu Medical Device Co.,Ltd. Reusable Insulin Injection Pen Product Portfolio
- 4.8.5 Jiangsu Delfu Medical Device Co.,Ltd. Recent Developments
- 4.9 Wanhai Medical
- 4.9.1 Wanhai Medical Company Information
- 4.9.2 Wanhai Medical Business Overview
- 4.9.3 Wanhai Medical Reusable Insulin Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Wanhai Medical Reusable Insulin Injection Pen Product Portfolio
- 4.9.5 Wanhai Medical Recent Developments
- 4.10 Phray Technology Co., Ltd.
- 4.10.1 Phray Technology Co., Ltd. Company Information
- 4.10.2 Phray Technology Co., Ltd. Business Overview
- 4.10.3 Phray Technology Co., Ltd. Reusable Insulin Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Phray Technology Co., Ltd. Reusable Insulin Injection Pen Product Portfolio
- 4.10.5 Phray Technology Co., Ltd. Recent Developments
- 4.11 Shanghai Umitai Medical Technology Co.,Ltd
- 4.11.1 Shanghai Umitai Medical Technology Co.,Ltd Company Information
- 4.11.2 Shanghai Umitai Medical Technology Co.,Ltd Business Overview
- 4.11.3 Shanghai Umitai Medical Technology Co.,Ltd Reusable Insulin Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Shanghai Umitai Medical Technology Co.,Ltd Reusable Insulin Injection Pen Product Portfolio
- 4.11.5 Shanghai Umitai Medical Technology Co.,Ltd Recent Developments
- 4.12 Shandong Kangli Medical Equipment Technology Co., Ltd.
- 4.12.1 Shandong Kangli Medical Equipment Technology Co., Ltd. Company Information
- 4.12.2 Shandong Kangli Medical Equipment Technology Co., Ltd. Business Overview
- 4.12.3 Shandong Kangli Medical Equipment Technology Co., Ltd. Reusable Insulin Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Shandong Kangli Medical Equipment Technology Co., Ltd. Reusable Insulin Injection Pen Product Portfolio
- 4.12.5 Shandong Kangli Medical Equipment Technology Co., Ltd. Recent Developments
- 4.13 Gangan Medical Technology Jiangsu Co., LTD
- 4.13.1 Gangan Medical Technology Jiangsu Co., LTD Company Information
- 4.13.2 Gangan Medical Technology Jiangsu Co., LTD Business Overview
- 4.13.3 Gangan Medical Technology Jiangsu Co., LTD Reusable Insulin Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Gangan Medical Technology Jiangsu Co., LTD Reusable Insulin Injection Pen Product Portfolio
- 4.13.5 Gangan Medical Technology Jiangsu Co., LTD Recent Developments
- 4.14 Lepu Medical Technology (Beijing) Co., Ltd.
- 4.14.1 Lepu Medical Technology (Beijing) Co., Ltd. Company Information
- 4.14.2 Lepu Medical Technology (Beijing) Co., Ltd. Business Overview
- 4.14.3 Lepu Medical Technology (Beijing) Co., Ltd. Reusable Insulin Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Lepu Medical Technology (Beijing) Co., Ltd. Reusable Insulin Injection Pen Product Portfolio
- 4.14.5 Lepu Medical Technology (Beijing) Co., Ltd. Recent Developments
5 Global Reusable Insulin Injection Pen Market Scenario by Region
- 5.1 Global Reusable Insulin Injection Pen Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Reusable Insulin Injection Pen Sales by Region: 2021-2032
- 5.2.1 Global Reusable Insulin Injection Pen Sales by Region: 2021-2026
- 5.2.2 Global Reusable Insulin Injection Pen Sales by Region: 2027-2032
- 5.3 Global Reusable Insulin Injection Pen Revenue by Region: 2021-2032
- 5.3.1 Global Reusable Insulin Injection Pen Revenue by Region: 2021-2026
- 5.3.2 Global Reusable Insulin Injection Pen Revenue by Region: 2027-2032
- 5.4 North America Reusable Insulin Injection Pen Market Facts & Figures by Country
- 5.4.1 North America Reusable Insulin Injection Pen Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Reusable Insulin Injection Pen Sales by Country (2021-2032)
- 5.4.3 North America Reusable Insulin Injection Pen Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Reusable Insulin Injection Pen Market Facts & Figures by Country
- 5.5.1 Europe Reusable Insulin Injection Pen Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Reusable Insulin Injection Pen Sales by Country (2021-2032)
- 5.5.3 Europe Reusable Insulin Injection Pen Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Reusable Insulin Injection Pen Market Facts & Figures by Country
- 5.6.1 Asia Pacific Reusable Insulin Injection Pen Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Reusable Insulin Injection Pen Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Reusable Insulin Injection Pen Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Reusable Insulin Injection Pen Market Facts & Figures by Country
- 5.7.1 South America Reusable Insulin Injection Pen Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Reusable Insulin Injection Pen Sales by Country (2021-2032)
- 5.7.3 South America Reusable Insulin Injection Pen Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Reusable Insulin Injection Pen Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Reusable Insulin Injection Pen Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Reusable Insulin Injection Pen Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Reusable Insulin Injection Pen Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Reusable Insulin Injection Pen Sales by Type (2021-2032)
- 6.1.1 Global Reusable Insulin Injection Pen Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Reusable Insulin Injection Pen Sales Market Share by Type (2021-2032)
- 6.2 Global Reusable Insulin Injection Pen Revenue by Type (2021-2032)
- 6.2.1 Global Reusable Insulin Injection Pen Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Reusable Insulin Injection Pen Revenue Market Share by Type (2021-2032)
- 6.3 Global Reusable Insulin Injection Pen Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Reusable Insulin Injection Pen Sales by Application (2021-2032)
- 7.1.1 Global Reusable Insulin Injection Pen Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Reusable Insulin Injection Pen Sales Market Share by Application (2021-2032)
- 7.2 Global Reusable Insulin Injection Pen Revenue by Application (2021-2032)
- 7.2.1 Global Reusable Insulin Injection Pen Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Reusable Insulin Injection Pen Revenue Market Share by Application (2021-2032)
- 7.3 Global Reusable Insulin Injection Pen Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Reusable Insulin Injection Pen Value Chain Analysis
- 8.1.1 Reusable Insulin Injection Pen Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Reusable Insulin Injection Pen Production Mode & Process
- 8.2 Reusable Insulin Injection Pen Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Reusable Insulin Injection Pen Distributors
- 8.2.3 Reusable Insulin Injection Pen Customers
9 Global Reusable Insulin Injection Pen Analyzing Market Dynamics
- 9.1 Reusable Insulin Injection Pen Industry Trends
- 9.2 Reusable Insulin Injection Pen Industry Drivers
- 9.3 Reusable Insulin Injection Pen Industry Opportunities and Challenges
- 9.4 Reusable Insulin Injection Pen Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst